Patient 5 and patient 16 showed mutations in TP53 and TET2, respectively, by the next‐generation sequencing assay, and patient 5 was diagnosed with unclassifiable indolent B-cell lymphoma simultaneously. This evidence concerns the gene TET2 and B-cell non-Hodgkin lymphoma.